Medical therapy of pulmonary hypertension -: Conventional therapies

The past two decades have witnessed important progress in the treatment of primary pulmonary disease (PPH). Although significant improvements in quality of life and survival rate have been obtained with prostacyclin therapy, and better perspectives are now offered with atrial septostomy and lung transplantation, conventional therapy has also evolved. Patients are now more adequately counseled regarding how to remain physically active while avoiding exercise-induced anginal pain and syncope. Invasive and potentially risky medical procedures have been restricted in favor of noninvasive and functional evaluations whenever possible.